Oracle Agile PLM MCAD Connector 3.6 CAX Client privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.9 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in Oracle Agile PLM MCAD Connector 3.6. It has been classified as critical. This affects an unknown part of the component CAX Client. Performing a manipulation results in privileges management. This vulnerability is cataloged as CVE-2026-71069. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability classified as critical has been found in Oracle Agile PLM MCAD Connector 3.6. This affects an unknown code block of the component CAX Client. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle Agile PLM MCAD Connector product of Oracle Supply Chain (component: CAX Client). The supported version that is affected is 3.6. Difficult to exploit vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Agile PLM MCAD Connector. Successful attacks of this vulnerability can result in takeover of Oracle Agile PLM MCAD Connector. CVSS 3.1 Base Score 7.5 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared at oracle.com. This vulnerability is uniquely identified as CVE-2026-71069 since 08/05/2026. The exploitability is told to be easy. It is possible to initiate the attack remotely. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 08/19/2026). MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.9VulDB Meta Temp Score: 6.9
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.5
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
08/05/2026 CVE reserved08/19/2026 Advisory disclosed
08/19/2026 VulDB entry created
08/19/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-71069 (🔒)
GCVE (CVE): GCVE-0-2026-71069
GCVE (VulDB): GCVE-100-392229
Entry
Created: 08/19/2026 02:01Changes: 08/19/2026 02:01 (62)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.